We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NRE
2001
DELISTED
NorthStar Realty Europe Corp.
NRE
| $887K | ﹤0.01% |
66,009
-10,015
| -13% | -$138K |
|
2002
AMC Entertainment Holdings
AMC
$2.52B
| $886K | ﹤0.01% |
5,869
-986
| -14% | -$138K |
|
2003
United Parks & Resorts
PRKS
$2.1B
| $881K | ﹤0.01% |
64,923
-14,289
| -18% | -$178K |
|
|
INOV
2004
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $878K | ﹤0.01% |
58,503
-11,203
| -16% | -$178K |
|
2005
Community Health Systems
CYH
$393M
| $877K | ﹤0.01% |
205,961
+5,500
| +3% | +$27.6K |
|
|
AVX
2006
DELISTED
AVX Corporation
AVX
| $876K | ﹤0.01% |
50,651
-8,389
| -14% | -$153K |
|
2007
Varonis Systems
VRNS
$4.59B
| $875K | ﹤0.01% |
54,087
-9,597
| -15% | -$151K |
|
|
SRDX
2008
DELISTED
Surmodics
SRDX
| $873K | ﹤0.01% |
31,168
+3,615
| +13% | +$110K |
|
|
SYNT
2009
DELISTED
Syntel Inc
SYNT
| $873K | ﹤0.01% |
37,980
-6,425
| -14% | -$152K |
|
2010
Astronics
ATRO
$3.43B
| $867K | ﹤0.01% |
28,856
-10,052
| -26% | -$272K |
|
2011
Bladex Inc
BLX
$2.2B
| $867K | ﹤0.01% |
32,215
-5,392
| -14% | -$156K |
|
2012
Cytokinetics
CYTK
$10.5B
| $860K | ﹤0.01% |
105,520
+17,464
| +20% | +$198K |
|
2013
OceanFirst Financial
OCFC
$1.68B
| $858K | ﹤0.01% |
32,703
-5,632
| -15% | -$153K |
|
2014
Travere Therapeutics
TVTX
$5.2B
| $857K | ﹤0.01% |
40,684
-7,390
| -15% | -$169K |
|
|
SUP
2015
DELISTED
Superior Industries International
SUP
| $855K | ﹤0.01% |
57,608
+7,194
| +14% | +$115K |
|
|
LBAI
2016
DELISTED
Lakeland Bancorp Inc
LBAI
| $853K | ﹤0.01% |
44,324
-8,020
| -15% | -$163K |
|
2017
Community Trust Bancorp
CTBI
$1.42B
| $851K | ﹤0.01% |
18,058
-2,735
| -13% | -$132K |
|
2018
Vicor
VICR
$9.56B
| $846K | ﹤0.01% |
40,479
+5,859
| +17% | +$131K |
|
|
CSR
2019
Centerspace
CSR
$921M
| $843K | ﹤0.01% |
14,839
-2,579
| -15% | -$153K |
|
|
FLXN
2020
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $843K | ﹤0.01% |
33,662
-385
| -1% | -$9.43K |
|
|
WEB
2021
DELISTED
Web.com Group, Inc.
WEB
| $843K | ﹤0.01% |
38,654
-6,858
| -15% | -$161K |
|
|
JAG
2022
DELISTED
Jagged Peak Energy Inc.
JAG
| $842K | ﹤0.01% |
53,329
-8,192
| -13% | -$118K |
|
2023
German American Bancorp
GABC
$1.91B
| $841K | ﹤0.01% |
23,797
-3,569
| -13% | -$131K |
|
2024
Future Fuel
FF
$217M
| $840K | ﹤0.01% |
59,597
+9,435
| +19% | +$141K |
|
|
WRD
2025
DELISTED
WildHorse Resource Development
WRD
| $834K | ﹤0.01% |
45,307
+19,252
| +74% | +$289K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.